GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Goodrx Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.079 Ladies and gentlemen, thank you for standing by and welcome to the GoodRx 00:00:05.079 -- 00:00:09.566 fourth quarter and full year 2025 earnings call. 00:00:09.566 -- 00:00:13.532 As a reminder, today's conference is being recorded. 00:00:13.532 -- 00:00:18.961 I would like now to introduce your host for today's call, Aubrey Reynolds, Director 00:00:18.961 -- 00:00:22.987 of Investor Relations. Ms. Reynolds, you may begin. 00:00:22.987 -- 00:00:24.987 Thank 00:00:25.591 -- 00:00:30.375 you, Operator. Good morning, everyone, and welcome to GoodRx's earnings conference call 00:00:30.375 -- 00:00:33.997 for the fourth quarter and full year 2025. 00:00:34.080 -- 00:00:38.847 Joining me today are Wendy Barnes, our chief executive officer, and Chris McGinnis, our 00:00:38.847 -- 00:00:41.311 chief financial officer. 00:00:41.311 -- 00:00:45.758 Before we begin, I'd like to remind everyone that this call will contain forward-looking 00:00:45.758 -- 00:00:47.620 statements. 00:00:47.620 -- 00:00:51.907 All statements made on this call that do not relate to matters of historical fact should 00:00:51.907 -- 00:00:56.711 be considered forward-looking statements, including, without limitation, statements regarding 00:00:56.711 -- 00:01:02.078 management's plans, strategies, goals and objectives, our market opportunity, 00:01:02.078 -- 00:01:07.084 our anticipated financial performance, underlying trends in our business and industry, 00:01:07.084 -- 00:01:12.010 including ongoing changes in the pharmacy ecosystem, our value proposition, our long-term 00:01:12.010 -- 00:01:17.257 growth prospects, our direct and hybrid contracting approach, collaborations and partnerships 00:01:17.257 -- 00:01:21.382 with third parties, including our point-of-s...